Ocular Therapeutix, Inc.
OCUL
$6.96
-$0.045-0.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -64.05M | -48.39M | -36.49M | -43.78M | -64.85M |
| Total Depreciation and Amortization | 981.00K | 951.00K | 959.00K | 956.00K | 920.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.87M | 7.15M | 186.00K | 14.89M | 43.05M |
| Change in Net Operating Assets | 5.53M | 858.00K | -1.21M | 3.13M | -13.01M |
| Cash from Operations | -44.67M | -39.43M | -36.56M | -24.80M | -33.89M |
| Capital Expenditure | -1.93M | -202.00K | -89.00K | -742.00K | -255.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.93M | -202.00K | -89.00K | -742.00K | -255.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.18M | 4.51M | 4.18M | 2.20M | 321.22M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.18M | 4.51M | 4.18M | 2.20M | 321.22M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -42.42M | -35.12M | -32.47M | -23.35M | 287.08M |